1. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT
    Caixia Sun et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. IRAK2 counterbalances oncogenic Smurf1 in colon cancer cells by dictating ER stress
    Jingwen Liu et al, 2018, Cellular Signalling CrossRef
  3. Smurfs in Protein Homeostasis, Signaling, and Cancer
    Praveen Koganti et al, 2018, Front. Oncol. CrossRef
  4. miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells
    Youmao Tao et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  5. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer.
    Mingkun Jiang et al, 2019, Cell Death Dis CrossRef
  6. Regulat-INGs in tumors and diseases: focus on ncRNAs
    Marjorie Gournay et al, 2019, Cancer Letters CrossRef
  7. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop
    Xiuhua Fan et al, 2019, J Cell Biochem CrossRef
  8. Casein Kinase 2 Interacting Protein-1 Suppresses Glioma Cell Proliferation via Regulating the AKT/GSK3β/β-Catenin Pathway
    Yan-Guo Xi et al, 2019, BioMed Research International CrossRef
  9. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma—A meta-analysis approach
    Ram Bhupal Reddy et al, 2019, PLoS ONE CrossRef
  10. The functions and regulations of Smurfs in cancers
    Lin Fu et al, 2019, Seminars in Cancer Biology CrossRef

  11. Antitumor Effect of miR-1294/Pyruvate Kinase M2 Signaling Cascade in Osteosarcoma Cells


    Quan Yuan et al, 2020, OTT CrossRef
  12. Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
    Pierre Gâtel et al, 2020 CrossRef
  13. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p
    Ziqi Peng et al, 2020, Technol Cancer Res Treat CrossRef
  14. Regulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer
    Andrea Rodríguez-Alonso et al, 2020, Cancers CrossRef
  15. SMURF1, a promoter of tumor cell progression?
    Qin Xia et al, 2020, Cancer Gene Ther CrossRef
  16. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance
    Huizhen Wang et al, 2021, J Mol Med CrossRef
  17. E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
    Abhishek Sinha et al, 2021, IJMS CrossRef
  18. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
    Guannan Wang et al, 2021, OTT CrossRef
  19. Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response
    Nicholas A. Mathieu et al, 2021, Front. Oncol. CrossRef
  20. Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line
    Chia-Hsin Hsu et al, 2021, PLoS ONE CrossRef
  21. Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy
    Jinxin Liu et al, 2022, Seminars in Cancer Biology CrossRef
  22. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment
    Yijie Wang et al, 2022, Pharmacology & Therapeutics CrossRef
  23. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
    Aiqin Sun et al, 2023, Pathol. Oncol. Res. CrossRef
  24. SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors
    Zhenlin Huang et al, 2023 CrossRef
  25. UPS: Opportunities and challenges for gastric cancer treatment
    Hang Yang et al, 2023, Front. Oncol. CrossRef
  26. NEDD4 E3 ubiquitin ligases: promising biomarkers and therapeutic targets for cancer
    Xianyan Tian et al, 2023, Biochemical Pharmacology CrossRef
  27. SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway
    Lei Dong et al, 2023, Cell Death Dis CrossRef
  28. Smurf1: A possible therapeutic target in dry age-related macular degeneration
    Duo Li et al, 2023, Experimental Eye Research CrossRef
  29. Smurf1 Modulates Smad Signaling Pathway in Fibrotic Cataract Formation
    Fanying Jiang et al, 2024, Invest. Ophthalmol. Vis. Sci. CrossRef
  30. Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies
    Srimathi Kasturirangan et al, 2024, Cell Death Dis CrossRef
  31. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression
    Disha V. Pandya et al, 2024, Mol Biol Rep CrossRef
  32. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications
    Rossella De Florian Fania et al, 2024, Cell Death Differ CrossRef
  33. Genomic Biology and Therapeutic Strategies of Liver Metastasis from Gastric Cancer
    Yichao Wang et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  34. NDRG1 enhances the sensitivity to Cetuximab by promoting Stat1 ubiquitylation in colorectal cancer
    Guang Yang et al, 2024, Journal of Advanced Research CrossRef
  35. SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription
    Lingling Chen et al, 2024, Biochemical Pharmacology CrossRef
  36. Highlighting roles of autophagy in human diseases: a perspective from single-cell RNA sequencing analyses
    Anis Khalafiyan et al, 2024, Drug Discovery Today CrossRef
  37. Overexpression of miR‑424‑5p reduces cisplatin resistance by downregulating SMURF1 in gastric cancer
    Daohan Wang et al, 2025, Oncol Lett CrossRef